Literature DB >> 7721640

Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation.

C G Willett1, G Warland, J Coen, P C Shellito, C C Compton.   

Abstract

PURPOSE: Regression of rectal carcinoma after preoperative irradiation is variable, likely reflecting differences in the physical and biologic properties of these tumors. This study examines the association between the pathologic response of rectal cancer after irradiation and its pretreatment proliferative state as assayed by the activity of the proliferative dependent antigens (Ki-67, PCNA) and mitotic counts. METHODS AND MATERIALS: One hundred and twenty-two patients with locally advanced rectal cancer received preoperative irradiation followed by surgery. Pretreatment tumor biopsies were scored for the extent of Ki-67 and PCNA immunostaining and the number of mitoses per 10 high-powered fields. Postirradiation surgical specimens were examined for extent of residual disease.
RESULTS: The tumors of 38 of 122 patients (31%) exhibited marked pathologic downstaging (no residual tumor or cancer confined to the rectal wall) after preoperative irradiation. Two features were associated with the likelihood of marked pathologic regression after preoperative irradiation: tumor proliferative activity and lesion size. When stratified by lesion size, marked tumor regression occurred most frequently in smaller tumors with high Ki-67, PCNA, and mitotic activity compared to larger tumors with lower Ki-67, PCNA, and mitotic activity. Intermediate downstaging rates were seen for small or large tumors with moderate Ki-67, PCNA, and mitotic activity.
CONCLUSION: Tumor Ki-67, PCNA, and mitotic activity predicts the likelihood of response to irradiation, which may aid in formulating treatment policies for patients with rectal cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721640     DOI: 10.1016/0360-3016(94)00457-V

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.

Authors:  Andrea Ambrosini-Spaltro; Fabrizio Salvi; Christine M Betts; Giovanni P Frezza; Antonio Piemontese; Pietro Del Prete; Cristina Baldoni; Maria P Foschini; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

2.  Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients.

Authors:  Anna Gasinska; Piotr Richter; Zbigniew Darasz; Joanna Niemiec; Krzysztof Bucki; Krzysztof Malecki; Andrzej Sokolowski
Journal:  J Gastrointest Surg       Date:  2011-06-25       Impact factor: 3.452

3.  Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy.

Authors:  Young Joo Park; Byung Ryul Oh; Sang Woo Lim; Jung Wook Huh; Jae Kyun Joo; Young Jin Kim; Hyeong Rok Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-08-31

4.  Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.

Authors:  Ji-In Bang; Seunggyun Ha; Sung-Bum Kang; Keun-Wook Lee; Hye-Seung Lee; Jae-Sung Kim; Heung-Kwon Oh; Ho-Young Lee; Sang Eun Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

5.  Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients.

Authors:  Byung Soh Min; Nam Kyu Kim; Ju Yeon Pyo; Hoguen Kim; Jinsil Seong; Ki Chang Keum; Seung Kook Sohn; Chang Hwan Cho
Journal:  J Korean Soc Coloproctol       Date:  2011-02-28

6.  Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.

Authors:  Anna Gasinska; Jan Skolyszewski; Tadeusz Popiela; Piotr Richter; Zbigniew Darasz; Krystyna Nowak; Joanna Niemiec; Beata Biesaga; Agnieszka Adamczyk; Krzysztof Bucki; Krzysztof Malecki; Marian Reinfuss; Teresa Kowalska
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

7.  Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.

Authors:  A S Allal; L Alonso-Pentzke; S Remadi
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.

Authors:  Ik Yong Kim; Sei Hwan You; Young Wan Kim
Journal:  BMC Surg       Date:  2014-11-18       Impact factor: 2.102

9.  Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Ren-Wen Huang; Yin-Kai Chao; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Sheng-Chieh Chan; Yun-Hen Liu
Journal:  World J Surg Oncol       Date:  2014-05-29       Impact factor: 2.754

10.  Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.

Authors:  Lu-Ning Zhang; Wei-Wei Xiao; Shao-Yan Xi; Pu-Yun OuYang; Kai-Yun You; Zhi-Fan Zeng; Pei-Rong Ding; Hui-Zhong Zhang; Zhi-Zhong Pan; Rui-Hua Xu; Yuan-Hong Gao
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.